Drugplain

MEDI-FIRST 400 [USP'U]/g

Bacitracin zinc, Neomycin sulfate, Polymyxin B sulfate · OINTMENT · Orazen Inc

No Recall History
Plain English

MEDI-FIRST is a ointment containing bacitracin zinc, neomycin sulfate, polymyxin b sulfate at 400 [USP'U]/g, taken topical. Manufactured by Orazen Inc.

Key Facts

Brand Name
MEDI-FIRST
Generic Name
Bacitracin zinc, Neomycin sulfate, Polymyxin B sulfate
NDC Code (Product)
71927-017
Manufacturer
Orazen Inc
Strength
400 [USP'U]/g
Dosage Form
OINTMENT
Route
TOPICAL
Marketing Status
Application #
M004
Marketing Start
09/03/2025

Recall History

No Recall History

Frequently Asked Questions

What is MEDI-FIRST used for?

MEDI-FIRST contains Bacitracin zinc, Neomycin sulfate, Polymyxin B sulfate. It is a ointment taken topical. Consult your doctor for specific uses.

Is MEDI-FIRST a controlled substance?

MEDI-FIRST is not classified as a controlled substance by the DEA.

What is the generic name for MEDI-FIRST?

The generic name for MEDI-FIRST is Bacitracin zinc, Neomycin sulfate, Polymyxin B sulfate. There are 12 other brand versions of Bacitracin zinc, Neomycin sulfate, Polymyxin B sulfate.

What is the NDC code for MEDI-FIRST 400 [USP'U]/g?

The NDC (National Drug Code) for MEDI-FIRST 400 [USP'U]/g is 71927-017, listed by Orazen Inc.